Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A 36 week, multicenter, randomized, double-blind, placebo- controlled, parallel-group study to evaluate the efficacy and safety of aliskiren on the prevention of left ventricular remodeling in high risk post-acute myocardial infarction patients when added to optimized standard therapy https://www.kusajili.fr:443/Trial/kT0ZzeMJ2kmIS65vThngTA%24a-36-week-multicenter-randomized-double-blind-placebo--controlled-parallel-group-study-to-evaluate-the-efficacy-and-safety-of-a
I have read and accept the terms of use of the site and the Privacy Policy
Send your message